Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #3294
Reference
CMO(2010)10
Name
Mephedrone
Categories
Scottish Government
CMO Letters
Organization
Scottish Government Health Directorates
Keywords
NHS
SCOTLAND
DRUG ABUSE
TREATMENT
RISKS
Description
This letter offers advice on handling users of mephedrone who may present to services for help, particularly given the extensive media coverage of the possible health risks of this drug and its classification as a Class B substance under the Misuse of Drugs Act on 16 April 2010.
Contact Name
Mr Gary Bannon
Contact Email
Contact Address
Contact Phone
Created
2010-04-29 00:00:00
Click to go back to homepage